Oncology Testing

A wide array of testing options are available for characterizing both solid and hematopoietic tumors including cytogenetic assays for the detection of copy number and structural alterations as well as sequencing assays for the detection of somatic mutations or fusion events. In addition, a testing protocol for hematopoietic tumors is offered which ensures proper selection of molecular assays for each sample based on review by an expert hematopathologist. Details and complete testing menus are available below.